ArticleAmerican journal of cancer research2020

Pre-transplant cytoreductive therapy can improve overall survival of patients with MDS-AML but not MDS-EB2 receiving HLA-matched sibling donor peripheral blood stem cell transplantation.

Qianqian Wang et al.PubMed ↗Full text ↗

No numbers read from the abstract.